Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
881,3 DKK | -0,79% | -2,29% | +26,24% |
Omzet 2024 * | 287 mld. 41,59 mld. 38,41 mld. | Omzet 2025 * | 345 mld. 49,98 mld. 46,17 mld. | Marktkapitalisatie | 3.932 mld. 570 mld. 527 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 103 mld. 14,97 mld. 13,83 mld. | Nettowinst (verlies) 2025 * | 124 mld. 17,96 mld. 16,58 mld. | EV/omzet 2024 * | 13,8 x |
Nettoschuld 2024 * | 26,04 mld. 3,78 mld. 3,49 mld. | Nettoschuld 2025 * | 3,19 mld. 463 mln. 427 mln. | EV/omzet 2025 * | 11,4 x |
K/w-verhouding 2024 * |
38,1
x | K/w-verhouding 2025 * |
31,3
x | Werknemers | 63.845 |
Dividendrendement 2024 * |
1,33% | Dividendrendement 2025 * |
1,61% | Vrij verhandelbaar | 70,47% |
Recentste transcriptie over Novo Nordisk A/S
1 dag | -0,79% | ||
1 week | -2,29% | ||
Lopende maand | +7,51% | ||
1 maand | +5,68% | ||
3 maanden | +27,36% | ||
6 maanden | +36,11% | ||
Lopend jaar | +26,24% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 01-01-91 | |
Director of Finance/CFO | 53 | 01-01-99 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 63 | 19-03-15 |
Helge Lund
CHM | Chairman | 61 | 23-03-17 |
Martin MacKay
BRD | Director/Board Member | 68 | 01-03-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
21.31% | 196 M€ | +12,18% | ||
10.45% | 5 M€ | +13,27% | ||
5.40% | 18 M€ | +7,01% | - | |
4.67% | 88 M€ | +10,37% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 881,3 | -0,79% | 2 544 307 |
26-03-24 | 888,3 | -0,69% | 2 930 730 |
25-03-24 | 894,5 | +0,82% | 1 462 573 |
22-03-24 | 887,2 | -0,75% | 2 198 005 |
21-03-24 | 893,9 | -0,90% | 3 529 581 |
uitgestelde koers Nasdaq Copenhagen, 27 maart 2024 om 16:59 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,24% | 571 mld. | |
+33,50% | 701 mld. | |
+0,78% | 381 mld. | |
+20,85% | 334 mld. | |
+16,38% | 319 mld. | |
+2,11% | 210 mld. | |
+1,34% | 210 mld. | |
-7,26% | 201 mld. | |
-3,51% | 157 mld. | |
-0,60% | 153 mld. |